Meticulous Research®, a renowned leader in global market research,
has unveiled its latest research report titled "Navigating the Future: Pharmaceutical
Automation Market Outlook—Component, Mode of Automation, End User, and
Geographical Analysis—Global Forecast up to 2029." This comprehensive
report delves into the intricacies of the pharmaceutical automation landscape,
offering valuable insights into its evolution and growth trajectory.
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5280
According to Meticulous Research®, the pharmaceutical automation
market is on track to achieve a valuation of $18.2 billion by 2029, exhibiting
a commendable CAGR of 12.0% during the forecast period from 2022 to 2029. The
market's ascent is underpinned by various factors, including the proliferation
of robots in pharmaceutical manufacturing, government initiatives aimed at
fostering industrial progress, increased investments in modernizing
conventional production facilities, and the burgeoning demand for secure and
digitalized production processes. Additionally, the surge in demand for
Industrial Internet of Things (IIoT) solutions in pharmaceutical manufacturing,
coupled with the unprecedented demand for vaccine manufacturing amid the
COVID-19 pandemic, is poised to unlock significant growth opportunities in this
market.
However, challenges such as the substantial initial investment
required for procuring automation hardware and software, coupled with the
scarcity of skilled labor and cybersecurity vulnerabilities associated with
automated systems, may pose impediments to market expansion.
Speck to our analyst @ https://www.meticulousresearch.com/speak-to-analyst/cp_id=5280
Key Highlights from the Report:
Segmentation Insights: The pharmaceutical automation market is segmented based on
components (enterprise-level controls, plant instrumentation, and plant-level
controls), mode of automation (semi-automatic and fully automatic systems), and
end users (pharmaceutical and biotech industries), providing stakeholders with
a granular understanding of market dynamics.
Component Analysis: In
2022, the enterprise-level controls segment is anticipated to command the
largest market share, attributed to the myriad benefits offered by solutions
such as product lifecycle management, enterprise resource planning, and
manufacturing execution systems. These solutions empower pharmaceutical manufacturers
to enhance productivity, efficiency, and time-to-market for new products,
thereby driving cost savings.
Mode of Automation:
Semi-automatic systems are poised to dominate the market in 2022, owing to
their versatility and capability to blend manual and machine-aided assemblies.
These systems, which require human intervention at the beginning and end of
processes, are instrumental in improving manufacturing processes while
retaining operator involvement.
Quick Buy @ https://www.meticulousresearch.com/Checkout/87904065
End-user Landscape:
The pharmaceutical industry segment is slated to capture the largest market
share in 2022, driven by the widespread adoption of continuous improvement
processes to bolster production flexibility, efficiency, and waste reduction.
Leading technology players like Microsoft, IBM, and Google are actively
developing automation and cloud solutions tailored for the pharmaceutical and
healthcare sectors, bolstering industry growth.
Geographical Analysis:
In 2022, Asia-Pacific is poised to emerge as the frontrunner in
the pharmaceutical automation market, followed closely by Europe and North
America. The dominance of Asia-Pacific can be attributed to heightened
technical awareness, particularly in countries like China, Japan, and
Singapore, coupled with robust pharmaceutical manufacturing capabilities. For
instance, institutions like Thailand's Mahidol University and the Institute of
Molecular Biosciences have leveraged advanced robotics solutions to handle samples
of viruses and antibodies, minimizing risks to human operators.
Key Market Players:
Leading players driving innovation and growth in the
pharmaceutical automation market include ABB Group, Rockwell Automation,
Siemens AG, Yaskawa Electric Corporation, Schneider Electric, Yokogawa Electric
Corporation, KUKA AG, Emerson Electric, Fanuc, Honeywell International,
Mitsubishi Electric Corporation, OMRON Corporation, Advantech Co., Ltd., and
Fuji Electric Co., Ltd.
Browse in depth @ https://www.meticulousresearch.com/product/pharmaceutical-automation-market-5280
No comments:
Post a Comment